Factor H–related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation
- 17 September 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 114 (12), 2439-2447
- https://doi.org/10.1182/blood-2009-02-205641
Abstract
Homozygous deletion of a 84-kb genomic fragment in human chromosome 1 that encompasses the CFHR1 and CFHR3 genes represents a risk factor for hemolytic uremic syndrome (HUS) but has a protective effect in age-related macular degeneration (AMD). Here we identify CFHR1 as a novel inhibitor of the complement pathway that blocks C5 convertase activity and interferes with C5b surface deposition and MAC formation. This activity is distinct from complement factor H, and apparently factor H and CFHR1 control complement activation in a sequential manner. As both proteins bind to the same or similar sites at the cellular surfaces, the gain of CFHR1 activity presumably is at the expense of CFH-mediated function (inhibition of the C3 convertase). In HUS, the absence of CFHR1 may result in reduced inhibition of terminal complex formation and in reduced protection of endothelial cells upon complement attack. These findings provide new insights into complement regulation on the cell surface and biosurfaces and likely define the role of CFHR1 in human diseases.Keywords
This publication has 34 references indexed in Scilit:
- Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathwayKidney International, 2009
- The Opportunistic Human Pathogenic FungusAspergillus fumigatusEvades the Host Complement SystemInfection and Immunity, 2008
- Translational Mini-Review Series on Complement Factor H: Genetics and disease associations of human complement factor HClinical and Experimental Immunology, 2007
- Complement factor H and the hemolytic uremic syndromeThe Journal of Experimental Medicine, 2007
- Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic SyndromePLoS Genetics, 2007
- The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native proteinClinical and Experimental Immunology, 2006
- De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndromeHuman Mutation, 2006
- ComplementThe New England Journal of Medicine, 2001
- ComplementThe New England Journal of Medicine, 2001
- C5 Convertase of the Alternative Pathway of ComplementOnline Journal of Public Health Informatics, 1998